Individual Response to Different Volumes of Resistance Training
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02179307|
Recruitment Status : Completed
First Posted : July 1, 2014
Last Update Posted : November 6, 2015
The literature is not clear as to which training volume to employ during initial phases of resistance training programs to ensure optimal muscular adaptations. The purpose of this study is therefore to compare effects of strength training with low versus moderate volume on muscular function and hypertrophy in previously untrained, healthy individuals. Furthermore, the investigators will relate individual variation in responses to proxy markers of individual training state, such as baseline muscular function and muscle fiber type.
The study will include 25 women and 25 men and will consist of a 12-week resistance training protocol. Each study participant will act as their own control, performing both the low- (1-set) and the moderate-volume (3-sets) protocol, allocated to either the dominant or non-dominant leg, in a stratified and randomized fashion.
Primary outcome measures are thigh muscle cross section area and unilateral knee extension strength. Additionally, muscle fiber type composition will be evaluated as well as additional parameters of muscular function.
The primary hypothesis is that low-volume protocols will be beneficial for individuals with glycolytic muscle phenotypes, whereas the opposite will be true for individuals with more aerobic phenotypes.
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Behavioral: 12-week progressive strength training protocol||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||42 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Determinants of Intra-individual Variation in Adaptability to Resistance Training of Different Volumes|
|Study Start Date :||August 2014|
|Actual Primary Completion Date :||April 2015|
|Actual Study Completion Date :||April 2015|
Experimental: Arm label 1-Set, 3-Set
12-week progressive strength training protocol of different volumes
Behavioral: 12-week progressive strength training protocol
Every study participant will complete 12 weeks of progressive strength training with one leg performing 1-set per exercise per session and the contralateral leg performing 3-sets per exercise per session. Allocation of dominant/non-dominant leg to either 1- or 3-set protocol will be done in a stratified, randomized fashion (stratified with regard to sex and baseline strength).
- Thigh muscle cross-sectional area [ Time Frame: Week 0 (baseline) and 12 (post training intervention) ]Changes in muscle cross sectional area of each thigh from baseline to post intervention, assessed by MRI.
- Unilateral knee-extension isometric strength [ Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention) ]Time course changes in maximum knee extensor, isometric strength evaluated at 120° knee angle (180° fully extended).
- Muscle strength [ Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention) ]Time course changes in maximum isoinertial strength defined by one-repetition maximum in leg press, knee extension, knee flexion, and bench press.
- Knee extensors and flexors force-velocity relationship [ Time Frame: Week 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention) ]Time course changes in torque measured during maximal voluntary isokinetic contraction at 60°, 120° and 240° ∙ sec-1.
- Blood hormonal profiles [ Time Frame: Week 0 (baseline), 2 and 12 (post training intervention) ]Resting (week 0, 2 and 12) and acutely exercise-induced (week 2) hormonal profiles (testosterone, insulin-like growth factor 1, growth hormone and cortisol) determined in serum from venous blood samples.
- Muscle fiber cross-sectional area [ Time Frame: Week 0 (baseline), 2 and 12 (post training intervention) ]Changes in muscle fiber cross-sectional area assessed by immunohistochemistry from muscle biopsy. Determined from muscle biopsy samples (Vastus lateralis).
- Protein expression [ Time Frame: Week 0 (baseline), 2 and 12 (post training intervention) ]Changes in relative abundance of contractile protein isoforms (myosin heavy chain). Modification of proteins related to muscle hypertrophy in relation to an acute exercise session (assessed during week 2 of the intervention). Determined from muscle biopsy samples (Vastus lateralis).
- Gene expression [ Time Frame: Week 0 (baseline), 2 and 12 (post training intervention) ]Changes in gene expression related to skeletal muscle hypertrophy and structural phenotype measured in steady state conditions (biopsy sampled in resting conditions, week 0, 2 and 12) and in relation to acute exercise (biopsy sampled 1-h after strength exercise, week 2). Determined from muscle biopsy samples (Vastus lateralis).
- Body composition changes [ Time Frame: Week 0 (baseline) and 12 (post training intervention) ]Changes in body compositions (lean mass and fat mass) from prior intervention to after intervention assessed by dual x-ray absorptiometry scan.
- Habitual physical activity [ Time Frame: Week 0 ]Self-reported prior habitual physical activity assessed by questionnaire and interview before training intervention
- Daily nutrient intake [ Time Frame: Week 6 ]Daily nutrient intake assessed by a 4-day food intake registration.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02179307
|Lillehammer University College|
|Principal Investigator:||Stian Ellefsen, PhD||Inland Norway University of Applied Sciences|